provides HUGO Gene Nomenclature Committee (HGNC) symbols, PharmGKB submission URLs, submission dates, and release dates. Table 2 provides HGNC symbols, HGNC names, synonyms, GenBank accession numbers, and locus IDs.
Pharmacogenetic Significance: Genetic variation in the ATP-binding cassette (ABC) family of efflux transporters may result in altered expression and/or function of the encoded proteins. Resulting changes in intestinal absorption, intestinal, hepatic, and renal elimination, and tissue distribution of therapeutic agents can lead to alterations in drug response and drug toxicity profiles. In particular, loss-of-function variants may lead to accumulation of drugs in both target and nontarget tissues, resulting in toxicity.
Pharmacological Significance: ABC transporters are expressed in the basolateral (blood-facing) or apical (lumen-facing) membrane of polarized epithelial cells of the liver, intestine, and kidneys, where they play a role in the absorption, distribution, and elimination of bulky, neutral, or negatively charged compounds. Expression of ABC transporters in capillary endothelial cells of the blood-brain, blood-placenta, blood-cerebrospinal fluid, and blood-testes barriers is a major determinant of the access of many drugs into these restricted sites. The overexpression of some ABC transporters is associated with drug resistance in tumors. Table 3 .
Endogenous and Xenobiotic Substrates: See
Functional Characteristics: ABC transporters are efflux transporters that are ATP-dependent. They facilitate the active efflux of compounds into either the lumen or blood for elimination or distribution.
Summary of Data Submitted:
Size of sample set assayed: ABCB1, ABCB4, ABCB11, ABCC1, and ABCC2: 247 (494 chromosomes Steroid and bile acid conjugates, nucleoside analogs, 6-mercaptopurine (6-MP), 9-(2-phosphonylmethoxyethyl)adenine (PMEA), cAMP, cGMP MRP5 6-MP, PMEA, low affinity for cyclic nucleotides MXR Anthracyclines, mitoxantrone, bisantrene, topotecan, SN-38
